Skip to main content Back to Top
Advertisement

3/17/2021

Misoprostol Tablets

Products Affected - Description

    • Cytotec oral tablet, Pfizer, 100 mcg, unit-dose blister pack, 100 count, NDC 00025-1451-34
    • Misoprostol oral tablet, Greenstone, 200 mcg, bottle, 60 count, NDC 59762-5008-01
    • Misoprostol oral tablet, Greenstone, 200 mcg, bottle, 100 count, NDC 59762-5008-02
    • Misoprostol oral tablet, Lupin, 100 mcg, bottle, 60 count, NDC 43386-0160-06 - discontinued
    • Misoprostol oral tablet, Lupin, 100 mcg, bottle, 120 count, NDC 43386-0160-12 - discontinued
    • Misoprostol oral tablet, Lupin, 200 mcg, bottle, 60 count, NDC 43386-0161-06 - discontinued
    • Misoprostol oral tablet, Lupin, 200 mcg, bottle, 100 count, NDC 43386-0161-01 - discontinued

Reason for the Shortage

    • Lupin discontinued misoprostol tablets.
    • Pfizer has Cytotec on shortage due to manufacturing delay.
    • Greenstone did not provide a reason for the shortage.

Available Products

    • Cytotec oral tablet, Pfizer, 100 mcg, bottle, 60 count, NDC 00025-1451-60
    • Cytotec oral tablet, Pfizer, 200 mcg, bottle, 60 count, NDC 00025-1461-60
    • Cytotec oral tablet, Pfizer, 200 mcg, bottle, 100 count, NDC 00025-1461-31
    • Misoprostol oral tablet, Greenstone, 100 mcg, bottle, 60 count, NDC 59762-5007-01
    • Misoprostol oral tablet, Greenstone, 100 mcg, bottle, 120 count, NDC 59762-5007-02

Estimated Resupply Dates

    • Greenstone has misoprostol 200 mcg tablets in 60 count and 100 count bottles on back order and the company estimates a release date of late-March 2021.
    • Pfizer has Cytotec 100 mcg tablets in unit-dose packs on back order and the company estimates a release date of late-May 2021.

Updated

Updated March 17, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 25, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.